Christine Hansen

Trusted strategic advising for the life science industry

Christine Hansen brings over 25 years of experience in intellectual property (IP) counseling, patent prosecution, patent landscape analysis, due diligence and freedom-to-operate opinions to her clients. Sophisticated large pharmaceutical companies as well as startup life science companies trust Christine to develop and implement patent strategies to protect their research and to defend against competitors.

Christine understands the global life sciences business and knows the tools available internationally to secure protection for innovation. She uses her knowledge in using reissue, reexamination and supplemental examination proceedings to craft the best results for her clients. Her experience extends to diverse life sciences subjects, such as:

• Small molecules
• Pharmaceutical formulations
• Antibodies
• Protein therapeutics
• Gene therapy
• Diagnostic methods

Clients appreciate her commitment to understanding their businesses and her creative solutions to their business needs. Christine's varied and sophisticated legal experience enables her to develop highly effective legal strategies and novel approaches to obtain patents on pharmaceutical inventions that have high value to her clients.

Christine is the Indianapolis office chair of the Intellectual Property Practice Group.

• Assists pharmaceutical companies with their patent needs. Christine has extensive work with innovator pharmaceutical companies handling Orange Book submissions, patent term extensions and other issues at the intersection of patent and FDA law.
• Drafts patent licensing agreements and joint research and development agreements. She handles agreements between universities or governmental entities and private-sector partners.
• Manages U.S. patent portfolios for pharmaceuticals, including blockbuster cardiovascular and hypertension drugs.
• Develops global patenting strategy for new research and argues effectively before patent offices for the allowance of her clients’ valuable life sciences patent applications.

• Design and implementation of a global patent strategy for a high-value West Coast startup biotech company.
• Oversaw due diligence for major acquisition of technology for recombinant production in yeast of industrial chemicals.
• Obtained global patent portfolio broadly protecting innovative conjugated protein therapeutics that were successfully litigated at trial, resulting in a large damage award and favorable global settlement.
• Extensive work in the agriculture industry for technology leader on patent freedom-to-operate issues for genetically modified crops, plant gene vector technology and on patenting of novel plant genes.
• Trusted advisor designing patenting strategy to protect next generation neurology drug formulations for Fortune 100 pharmaceutical client.